Anti-CD3 Monoclonal Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-CD3 Monoclonal Antibody, covering 2011-10-25 to 2011-10-25. Get the full timeline:
Most recent: Clinical Trial Update: Oral Administration of Anti-CD3 Monoclonal Antibody in Non-responder Genotype-I Chronic Hepatitis C Subjects [Phase 2]